BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 25950327)

  • 1. HPV Testing by Hybrid Capture Assay Is a Valuable Second-Level Screening Procedure in Triage of Women with ASCUS Favor Reactive and ASCUS Favor Dysplasia Pap Smears.
    Krumholz B; Kuperman L
    J Low Genit Tract Dis; 1999 Jan; 3(1):48. PubMed ID: 25950327
    [No Abstract]   [Full Text] [Related]  

  • 2. The Triage of Women with ASCUS Cytology Using Human Papillomavirus DNA Testing.
    Kuperman L; Krumholz BA
    J Low Genit Tract Dis; 2000 Jan; 4(1):1-6. PubMed ID: 25950782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid Capture Human Papillomavirus Testing as an Adjunct to the Follow-Up of Patients with ASCUS and LGSIL Pap Smears: A Study of a Screening Population.
    McLachlin CM; Alanen KW; Elit LM; Smith EA; Kerkvliet NA
    J Low Genit Tract Dis; 2000 Jan; 4(1):12-7. PubMed ID: 25950784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
    Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
    J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear.
    Pitman MB; Cibas ES; Powers CN; Renshaw AA; Frable WJ
    Cancer; 2002 Jun; 96(3):128-34. PubMed ID: 12115299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the performance of reflex Human Papilloma Virus (HPV) testing in triaging women with atypical squamous cells of undetermined significance (ASCUS): A restrospective study in a tertiary hospital in United Arab Emirates (UAE).
    Fakhreldin M; Elmasry K
    Vaccine; 2016 Feb; 34(6):823-30. PubMed ID: 26747717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV DNA testing in the triage of atypical squamous cells of undetermined significance (ASCUS): cost comparison of two methods.
    Layfield LJ; Qureshi MN
    Diagn Cytopathol; 2005 Aug; 33(2):138-43. PubMed ID: 16007672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group.
    J Natl Cancer Inst; 2000 Mar; 92(5):397-402. PubMed ID: 10700419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV testing in the evaluation of the minimally abnormal Papanicolaou smear.
    Apgar BS; Brotzman G
    Am Fam Physician; 1999 May; 59(10):2794-801. PubMed ID: 10348071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV DNA Testing by Hybrid Capture Does Not Appear to be Useful in the Triage of Cytology Read as ASCUS-Favor Dysplasia, or as LGSIL.
    Cox JT; Gott P
    J Low Genit Tract Dis; 1999 Jan; 3(1):44. PubMed ID: 25950318
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
    Duncan L; Jacob S; Hubbard E
    Cancer; 2008 Feb; 114(1):34-48. PubMed ID: 18186493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus typing in HIV-positive women.
    Hameed M; Fernandes H; Skurnick J; Moore D; Kloser P; Heller D
    Infect Dis Obstet Gynecol; 2001; 9(2):89-93. PubMed ID: 11495559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of tetraploid cervical cells in human papillomavirus-positive Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance.
    Olaharski AJ; Eastmond DA
    Cancer; 2004 Jun; 102(3):192-9. PubMed ID: 15211479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
    Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
    Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria.
    Thrall MJ; Pambuccian SE; Stelow EB; McKeon DM; Miller L; Savik K; Gulbahce HE
    Cancer; 2008 Jun; 114(3):171-9. PubMed ID: 18454461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCR study of a series of ASCUS cases HPV-positive by HCII.
    Alameda F; Bellosillo B; Lloveras B; Pairet S; Musset M; Pijuan L; MariƱoso L; Mancebo G; Larrazabal F; Carreras R; Serrano S
    Diagn Cytopathol; 2012 Dec; 40(12):1043-6. PubMed ID: 21656701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility?
    Howard K; Salkeld G; McCaffery K; Irwig L
    Health Econ; 2008 May; 17(5):593-605. PubMed ID: 17764095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV testing: where are we now?
    Bovicelli A; Bristow RE; Montz FJ
    Anticancer Res; 2000; 20(6C):4673-80. PubMed ID: 11205199
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.